Theratechnologies Announces Financial Results for the Second Quarter of 2019

NEXT STORY
Manasi Patwardhan Joins BioSig as Director of Strategic Planning
PREV STORY
Forty Seven, Inc. and Ono Pharmaceutical Co., Ltd. Sign Regional License Agreement to Develop, Manufacture and Commercialize 5F9 in Japan, South Korea, Taiwan and Select Countries in Southeast Asia
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New Clinical Data Support the Utility of Epi proColon® Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome

author_avatar
NASDAQ Market News

Blood Culture Test Market Size to Reach $8.18 Billion by 2027: Allied Market Research

author_avatar
NASDAQ Market News

CymaBay Announces the Appointment of Sujal Shah as President and Chief Executive Officer

NEWARK, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage ...

author_avatar
NASDAQ Market News